CN102127552A - CPTI (Cowpea Trypsin Inhibitor) gene, applications thereof and method for preparing great amount of CPTI - Google Patents

CPTI (Cowpea Trypsin Inhibitor) gene, applications thereof and method for preparing great amount of CPTI Download PDF

Info

Publication number
CN102127552A
CN102127552A CN 201010590327 CN201010590327A CN102127552A CN 102127552 A CN102127552 A CN 102127552A CN 201010590327 CN201010590327 CN 201010590327 CN 201010590327 A CN201010590327 A CN 201010590327A CN 102127552 A CN102127552 A CN 102127552A
Authority
CN
China
Prior art keywords
cpti
trypsin inhibitor
gene
cowpea trypsin
cowpea
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 201010590327
Other languages
Chinese (zh)
Other versions
CN102127552B (en
Inventor
高伟
李峰
陆庆宇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Forestry University
Original Assignee
Beijing Forestry University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Forestry University filed Critical Beijing Forestry University
Priority to CN 201010590327 priority Critical patent/CN102127552B/en
Publication of CN102127552A publication Critical patent/CN102127552A/en
Application granted granted Critical
Publication of CN102127552B publication Critical patent/CN102127552B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Abstract

The invention relates to genetic engineering, in particular to a CPTI (Cowpea Trypsin Inhibitor), the applications thereof and a method for preparing a great amount of CPTIs. The inventor of the invention firstly directly obtains a CPTI gene (without introne) from a cowpea gene group DNA (Deoxyribonucleic Acid) by utilizing a PCR (Polymerase Chain Reaction) and then optimizes and modifies the CPTI sequence so that the expression quantity and the expression specific activity of the modified sequence in colon bacillus are remarkably improved.

Description

A kind of cowpea trypsin inhibitor gene and use, prepare in a large number the method for Cowpea Trypsin Inhibitor
Technical field
The present invention relates to the genetically engineered field, particularly, the present invention relates to a kind of cowpea trypsin inhibitor gene and use, prepare in a large number the method for Cowpea Trypsin Inhibitor.
Background technology
Cowpea Trypsin Inhibitor (cowpea trypsin inhibitor, CPTI) be the serpin of a kind of Bowman-Birk of belonging to family, can form the mixture of enzyme-inhibitor with the serine protease in Agricultural pests (mainly being lepidopteran, Orthoptera, the coleopteron) digestive tube, thereby weaken or the digestion hydrolytic action of blocks protein enzyme, and then it is malnutritive that insect is produced, and the disorder even the phenomena of mortality occur.Compare with traditional Bt albumen, CPTI albumen have press down worm or insecticidal spectrum is wider, to advantages such as person poultry safeties, be a kind of potential development object of biological pesticide, thereby have very high application and promotional value in agroforestry.
Coli expression system is present most widely used prokaryotic expression system, mainly is made up of expression vector and host bacterium two portions.Expression vector generally has following feature: stable genetic replication, ability goes down to posterity; Has selection markers; Regulatable promotor, the background transcriptional level is lower during inhibition; Possesses the multiple clone site that foreign gene inserts.The host bacterium is generally selected the bacterial strain of proteolytic enzyme defective, is exactly lon and ompT protease-deficient as the serial bacterial strain of the BL21 of classics.
But be not that all foreign genes can both efficiently express in escherichia expression system, the present inventor finds that the Cowpea Trypsin Inhibitor that the clone obtains from cowpea can not efficiently express in intestinal bacteria, its expression amount is lower, and the expressed proteins activity is lower.
Summary of the invention
In order to address the above problem, the present inventor proposes and has finished the present invention.
The purpose of this invention is to provide a kind of cowpea trypsin inhibitor gene.
A further object of the present invention provides a kind of Cowpea Trypsin Inhibitor.
Another object of the present invention provides a kind of Cowpea Trypsin Inhibitor prokaryotic expression carrier.
Another object of the present invention provides a kind of method of efficient, great expression Cowpea Trypsin Inhibitor.
Another object of the present invention provides a kind of engineering strain of efficient, great expression Cowpea Trypsin Inhibitor.
Another object of the present invention provides the application of above-mentioned cowpea trypsin inhibitor gene.
The present inventor at first utilizes the PCR reaction directly to obtain CPTI gene (the CPTI gene does not contain intron) from the cowpea genomic dna as mentioned above, 106 amino acid of the open reading frame of CPTI gene coding, this proteins encoded N end have 18 amino acid whose signal peptides (SignalP:http: //www.cbs.dtu.dk/services/SignalP/).This gene at expression in escherichia coli, is found that its expression amount is lower, and the expressed proteins activity is lower.
Because prokaryotic expression system does not have identification eukaryotic cell signal peptide usually also with the localized function of this albumen success, and ripe activated albumen always could form behind signal peptidase excision signal peptide, the synchronous signal peptide mainly contains hydrophobic amino acid, usually forms inclusion body in prokaryotic expression system during great expression.Therefore, the present inventor has removed the part signal peptide sequence when expressing above-mentioned CPTI gene, optimized sequence simultaneously according to removing signal peptide sequence as much as possible, guaranteeing not destroy the principle of proteic secondary structure again, preceding 30 deoxyribonucleotides of gene are removed, be beneficial to the recombinant protein that goes out this gene at expression in escherichia coli.Encoding sequence with the CPTI gene of transformation and optimization is building up among the prokaryotic expression carrier PGEX-6p-1 then; Subsequently the CPTI expression vector that builds is transformed among the expression strain BL21 (DE3), induces Expression of Fusion Protein with inductor IPTG (isopropyl-β-d-1-thiogalactopyranoside, sec.-propyl-β-d-thiogalactoside); Utilize fusion rotein the GST label can with the affine characteristic of Glutathione Sephrose 4B, can purifying obtain purity and reach fusion rotein GST-CPTI more than 90%.
The sequence of optimizing back CPTI gene is shown in SEQ ID No.1:
cttgtagggg?ttactactgc?agccatggat?ctgaaccacc?tcggaagtaa?tcatcatgat 60
gactcaagcg?atgaaccttc?tgagtcttca?gaaccatgct?gcgattcatg?catctgcact 120
aaatcaatac?ctcctcaatg?ccattgtaca?gatatcaggt?tgaattcgtg?tcactcggct 180
tgcaaatcct?gcatgtgtac?acgatcaatg?ccaggcaagt?gtcgttgcct?tgacattgct 240
gatttctgtt?acaaaccttg?caagtccagg?gatgaagatg?atgag 285
According to Cowpea Trypsin Inhibitor of the present invention, it is by the genes encoding of nucleotide sequence shown in SEQ ID No.1, and particularly, it has the aminoacid sequence shown in SEQ ID No.2.
LVGVTTAAMD?LNHLGSNHHD?DSSDEPSESS?EPCCDSCICT?KSIPPQCHCTDIRLNSCHSA 60
CKSCMCTRSM?PGKCRCLDIA?DFCYKPCKSR?DEDDE 95
Therefore, according to Cowpea Trypsin Inhibitor prokaryotic expression carrier of the present invention, it comprises above-mentioned Cowpea Trypsin Inhibitor CPTI gene.
Method efficient, the great expression Cowpea Trypsin Inhibitor according to the present invention is included in expresses the above-mentioned step of stating cowpea trypsin inhibitor gene in the prokaryotic organism, preferably at expression in escherichia coli.
According to the engineering strain of efficient, great expression Cowpea Trypsin Inhibitor of the present invention, it has above-mentioned cowpea trypsin inhibitor gene, is preferably the intestinal bacteria recombinant bacterial strain.
Though Cowpea Trypsin Inhibitor content in some beans is abundanter, but the technology of natural extract and purifying CPTI is loaded down with trivial details, yield poorly and the cost height, be not suitable for large-scale promotion and application, restricted the proteic application of CPTI at agricultural field control lepidoptera pest.
Optimization CPTI gene of the present invention can efficiently express in intestinal bacteria, and expression amount significantly improves, and the also raising alive of the ratio of expressing protein, when inhibitor concentration is 0.05mg/mL, suppress activity and reach 0.204, when inhibitor concentration is 0.2mg/mL, suppresses activity and reach 0.807.
Intestinal bacteria (E.coli) expression system is a present most widely used exogenous gene expression system.The advantage of coli expression system is that genetics and physiology background are clear; Cultivate easily, particularly high density fermentation; Foreign gene often can reach and efficiently express.Used coli strain BL21 (DE3).BL21 (DE3) is the lysogenic bacteria of a λ DE3 (λ DE3 is the mutant strain of lambda particles phage), promptly is integrated with one section karyomit(e) of λ DE3 on the karyomit(e) of BL21.Expression vector used in the present invention is that (GE Healthcare) has the derivable strong promoter of Ptac to PGEX-6p-1, gives expression to the fusion rotein that the N end has the GST label of a 26kDa.GST is as a kind of label of purifying, the very high target protein of purifying purity easily, and GST also has the proteic effect of the less CPTI of stable molecule amount simultaneously.
Description of drawings
Fig. 1 is the pcr amplification product of cowpea CPTI gene, M:DNA molecular weight standard, 1: negative control, 2:CPTI gene.
Fig. 2 is the double digestion checking of PGEX-6p-1-CPTI expression vector, 1: the product of recombinant plasmid double digestion, M:DNA molecular weight standard.
Fig. 3 is that fusion rotein GST-CPTI abduction delivering detects M: albumen Marker, 1:IPTG inductive bacterium liquid, 2: do not add IPTG inductive bacterium liquid.
Fig. 4 is a fusion rotein GST-CPTI affinitive layer purification, M: albumen Marker, 1: the fusion rotein GST-CPTI behind the purifying.
Fig. 5 is that trypsin inhibitor is active to tryptic inhibition.
Embodiment
The extraction of embodiment 1 cowpea genomic dna and the amplified production of CPTI gene
(cowpea trypsin inhibitor CPTI) does not contain intron to Cowpea Trypsin Inhibitor in the gene, by extracting the cowpea genomic dna, the sequences Design primer according to delivering out amplifies the CPTI gene.
Cowpea seed (available from the Chinese Academy of Agricultural Sciences) is planted in flowerpot, gets its blade after about 30 days and extracts genomic dna.Adopt The chargeswitch gDNA plant kit (available from invitrogen company) to extract the cowpea genomic dna.With above-mentioned cowpea genomic dna is template, utilizes the PCR reaction to amplify CPTI gene (Fig. 1).The PCR product of CPTI gene is sent to Shanghai and gives birth to the order-checking of worker's biotechnology company limited.Sequencing result shows: the encoding sequence of CPTI gene is made up of 321bp base, and 106 amino acid of encoding contain a terminator codon, the very high homology (more than 90%) with delivering sequence.
Embodiment 2 transforms the CPTI gene
106 amino acid of the open reading frame of CPTI gene coding, this proteins encoded N end have 18 amino acid whose signal peptides (SignalP: Http:// www.cbs.dtu.dk/services/SignalP/).Prokaryotic expression system does not have identification eukaryotic cell signal peptide usually also with the localized function of this albumen success, and ripe activated albumen always could form behind signal peptidase excision signal peptide, the synchronous signal peptide mainly contains hydrophobic amino acid, usually forms inclusion body in prokaryotic expression system during great expression.According to removing signal peptide sequence as much as possible, guarantee not destroy the principle of proteic secondary structure again, preceding 30 deoxyribonucleotides of gene are removed.The expressed CPTI of the present invention is from 106 amino acid of the 11st amino acid to the.Design upstream and downstream primer is also introduced restriction enzyme site BamH I and Xho I respectively.
Upstream primer CPTI-BamH I-F:gaa att ggatcc ctt gta ggg gtt act act
Downstream primer CPTI-Xho I-R:gaa att ctc gag ctc atc atc ttc atc
The PCR response procedures is: 95 ℃ of thermally denatures 5 minutes; 95 ℃ of sex change 30 seconds, 55 ℃ of annealing 30 seconds, 72 ℃ were extended 30 seconds; 30 circulations, 72 ℃ were extended 10 minutes.The PCR product is cut glue and is reclaimed the goal gene band through 1% agarose gel electrophoresis.
The structure of embodiment 3GST-CPTI fusion protein expression vector
BamH I and Xho I double digestion CPTI gene band and PGEX-6p-1 expression vector, 16 ℃ of connections of spending the night under T4 ligase effect.To connect product and transform DH5 α competent cell next day, and coating contains ammonia benzyl microbiotic solid LB flat board, 37 ℃ of incubated overnight.The clone that bacterium colony PCR is positive extracts plasmid and cuts checking (Fig. 2) as enzyme.Plasmid is sent to Shanghai gives birth to the order-checking of worker company, the result shows that the structure of expression vector is entirely true.
Embodiment 4GST-CPTI Expression of Fusion Protein
The expression vector plasmid that builds is transformed expression strain BL21 (DE3).Picking list bacterium colony is to containing in the antibiotic liquid LB of the 100 μ g/ml ammonia benzyls substratum, 37 ℃ of cultivations when treating that OD600 reaches 0.5 left and right sides, are taken out 500 μ l bacterium liquid and are done contrast, residue bacterium liquid adds IPTG to final concentration 0.5mmol/L abduction delivering, and 37 ℃ are continued to cultivate 3 hours.Get 500 μ l bacterium liquid, centrifugal 1 minute of 12000rpm collects thalline, with the resuspended thalline of 80 μ lPBS, adds 20 μ l 5x SDS-PAGE loading buffer, and boiling water boiled 5 minutes, got 10 μ l and carried out SDS-PAGE gel electrophoresis (electrophoresis result is seen Fig. 3).
The purifying of embodiment 5GST-CPTI fusion rotein
The picking mono-clonal contains in the antibiotic liquid LB of the ammonia benzyl substratum in 20ml, 37 ℃ of incubated overnight.The activatory bacterial classification is inoculated in 1L in 1: 100 ratio contains in the antibiotic fresh LB substratum of ammonia benzyl, 37 ℃, 200rpm cultivates two hours to OD600=0.5, and adding IPTG is 0.2mmol/L to final concentration, and 16 ℃ are spent the night and induce.4 ℃ of inferior daily large capacity refrigerated centrifuges, 4000rpm, 30 minutes collection thalline.Use 30ml PBS resuspended then, ultrasonic degradation under the ice bath.4 ℃ of high speed freezing centrifuges of cell lysate, centrifugal 30 minutes of 15000rpm.The supernatant that obtains is splined on the chromatography column with PBS equilibrated Glutathione Sephrose 4B with the flow velocity of 1ml/min, treat end of the sample after, continue to wash the albumen of non-specific binding with the PBS of 20 times of column volumes.Use elutriant (pH 8.0 for 10mmol/L reduced glutathion, 50mmol/L Tris-HCl) the wash-out target protein of 3 times of column volumes then.The purity (Fig. 4) of polyacrylate hydrogel electrophoresis detection fusion rotein adds 10kDaMillipore with the target protein that elutes and concentrates in the centrifuge tube, change Glutathione Sephrose 4B elutriant into 20mmol/L Tris pH 8.0,100mmol/LNaCl, 3mmol/L DTT also is concentrated into 1.5ml.-20 ℃, preserve.Utilize this proteic 280nm absorbance of spectrophotometer measurement, calculate in the 1L bacterium liquid and can obtain 25mg GST-CPTI albumen.
Embodiment 6 fusion rotein GST-CPTI are to the active mensuration of tryptic inhibition
(1) enzyme is lived and is suppressed the determination of activity principle:
Trypsinase can act on synthetic substrate benzoyl-DL-arginine p-Nitroaniline (BAPNA), discharges the xanchromatic p-Nitroaniline, and this material has obtained the maximum absorption under 410nm.Trypsin inhibitor can suppress this reaction, and the 410nm absorbance is descended, and its decline degree is directly proportional with trypsin inhibitor activity.With the variation of spectrophotometer, can carry out quantitative analysis to trypsin inhibitor activity at 410nm place mensuration absorbance.
(2) preparation of solution
Take by weighing trypsinase 30.0mg (Trypsin 1:250, porcine pancrease) and be dissolved in 5mmol/L CaCl 2With 1mmol/LHCl solution (pH3.0), and be settled to 100ml.Be stored in 4 ℃ of refrigerators.
The BAPNA that takes by weighing 60mg uses 50mmol/LTris-HCl (pH8.1) and 5mmol/L CaCl then with 1ml dimethyl sulfoxide (DMSO) (DMSO) dissolving 2Solution is settled to 100ml.
(3) fusion rotein GST-CPTI suppresses the measuring method of tryptic activity:
Control group:
The Protein G ST-CPTI (different concns) that gets 200 μ l purifying is in 750 μ l BAPNA solution (37 ℃ of preheatings), and 37 ℃ were reacted 10 minutes, stopped this reaction with 100 μ l acetums immediately, added 200 μ l trypsinase then, mixed.With water is blank, and 410nm measures absorbance A1.
The inhibition group:
The Protein G ST-CPTI (different concns) that gets 200 μ l purifying joins in the 750 μ l BAPNA solution (37 ℃ of preheatings), adds 200 μ l trypsin solutions then, and 37 ℃ were reacted 10 minutes, and stopped this reaction with 100 μ l acetums immediately.With water is blank, and 410nm measures absorbance A2.
The unrestraint group:
Get 200 μ l trypsin solutions and join in the 750 μ l BAPNA solution (37 ℃ of preheatings), 37 ℃ were reacted 10 minutes, added 100 μ l acetums and stopped this reaction, and then add the Protein G ST-CPTI (different concns) of 200 μ l purifying, mixed.With water is blank, and 410nm measures absorbance A3.
Fusion rotein GST-CPTI is to the inhibition of tryptic activity
The results are shown in Figure five.
Above-mentioned experimental data result shows along with the rising of inhibitor (GST-CPTI) concentration is just high more to tryptic inhibition degree.The Cowpea Trypsin Inhibitor (GST-CPTI) of this method preparation has kept combining activity with tryptic higher biology, and this lays a good foundation for the development and use of trypsin inhibitor and popularization.
Figure ISA00000387198000011

Claims (9)

1. a cowpea trypsin inhibitor gene is characterized in that, it has the nucleotide sequence shown in SEQ ID No.1.
2. a Cowpea Trypsin Inhibitor is characterized in that, described Cowpea Trypsin Inhibitor is by the genes encoding of nucleotide sequence shown in SEQ ID No.1.
3. a Cowpea Trypsin Inhibitor is characterized in that, it has the aminoacid sequence shown in SEQ ID No.2.
4. a Cowpea Trypsin Inhibitor prokaryotic expression carrier is characterized in that, described carrier comprises the described cowpea trypsin inhibitor gene of claim 1.
5. the method for efficient, a great expression Cowpea Trypsin Inhibitor is characterized in that described method is included in and expresses the step that comprises the described cowpea trypsin inhibitor gene of claim 1 in the prokaryotic organism.
6. method according to claim 5 is characterized in that described method is included in the step that expression in escherichia coli comprises the described cowpea trypsin inhibitor gene of claim 1.
7. the engineering strain of efficient, a great expression Cowpea Trypsin Inhibitor is characterized in that described bacterial strain has the described cowpea trypsin inhibitor gene of claim 1.
8. the engineering strain of efficient, a great expression Cowpea Trypsin Inhibitor is characterized in that described bacterial strain is the intestinal bacteria with the described cowpea trypsin inhibitor gene of claim 1.
9. the application of the described cowpea trypsin inhibitor gene of claim 1.
CN 201010590327 2010-12-08 2010-12-08 CPTI (Cowpea Trypsin Inhibitor) gene, applications thereof and method for preparing great amount of CPTI Expired - Fee Related CN102127552B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201010590327 CN102127552B (en) 2010-12-08 2010-12-08 CPTI (Cowpea Trypsin Inhibitor) gene, applications thereof and method for preparing great amount of CPTI

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201010590327 CN102127552B (en) 2010-12-08 2010-12-08 CPTI (Cowpea Trypsin Inhibitor) gene, applications thereof and method for preparing great amount of CPTI

Publications (2)

Publication Number Publication Date
CN102127552A true CN102127552A (en) 2011-07-20
CN102127552B CN102127552B (en) 2013-02-13

Family

ID=44265826

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201010590327 Expired - Fee Related CN102127552B (en) 2010-12-08 2010-12-08 CPTI (Cowpea Trypsin Inhibitor) gene, applications thereof and method for preparing great amount of CPTI

Country Status (1)

Country Link
CN (1) CN102127552B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102558360A (en) * 2012-01-15 2012-07-11 山西大学 Trypsin inhibitor and preparation method and application thereof
CN107449905A (en) * 2017-08-09 2017-12-08 华中农业大学 A kind of artificial microballoon for detecting rice Cowpea Trypsin Inhibitor

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070006351A1 (en) * 2004-02-13 2007-01-04 The Scotts Company Method for regenerating and transforming St. Augustinegrass from embryogenic callus

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070006351A1 (en) * 2004-02-13 2007-01-04 The Scotts Company Method for regenerating and transforming St. Augustinegrass from embryogenic callus

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
《GenBank》 20070827 Wang X et al EU088405 Vigna unguiculata trypsin inhibitor (CpTI) gene 1-9 , 2 *
《生物工程学报》 20030131 杨丽琛等 CpTI 蛋白在大肠杆菌中的高效融合表达及其纯化与活性测定 1-9 第19卷, 第1期 2 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102558360A (en) * 2012-01-15 2012-07-11 山西大学 Trypsin inhibitor and preparation method and application thereof
CN107449905A (en) * 2017-08-09 2017-12-08 华中农业大学 A kind of artificial microballoon for detecting rice Cowpea Trypsin Inhibitor

Also Published As

Publication number Publication date
CN102127552B (en) 2013-02-13

Similar Documents

Publication Publication Date Title
RU2006103365A (en) INSECTICIDAL PROTEINS ISOLATED FROM SPECIES OF BACILLUS BACTERIA AND THEIR APPLICATION
EA014887B1 (en) Method for the expression of insulin in plant seeds, a method for obtaining plant seeds comprising insulin and a plant capable of setting seeds comprising insulin
CN101736024B (en) Thaumatin-like protein gene PpTLP from pyrus pyrifolia nakai with antifungal activity and application
CN1938427A (en) Expression of plasminogen and microplasminogen in duck weed
CN110922457A (en) Plant immune induced resistance protein FgPII1 secreted by fusarium graminearum and application thereof
CN102978218A (en) Cloning of apple stress-resistant related gene MdSIMYB2 and application of cloning of apple stress-resistant related gene MdSIMYB2
CN102127552B (en) CPTI (Cowpea Trypsin Inhibitor) gene, applications thereof and method for preparing great amount of CPTI
CN103194457A (en) Lilium regale germin-like protein gene LrGLP2 and application thereof
CN110408624A (en) A kind of Ruditapes philippinarum c-type agglutinant protein and the preparation method and application thereof
CN108558992B (en) Transcription factor PDD1 for regulating and controlling growth of needle mushroom fruiting body and coding gene and application thereof
CN104878019A (en) Yangbi walnut germin-like protein gene JsGLP1 and application thereof
CN101748144B (en) Torch pear haloduric gene PpGST and application thereof
Visetnan et al. Kazal-type serine proteinase inhibitors from the black tiger shrimp Penaeus monodon and the inhibitory activities of SPIPm4 and 5
CN103981194A (en) Tobacco cadmium transporter gene NtHMA2, and cloning method and application thereof
CN103194466A (en) Lilium regale glutathione S-transferase gene LrGSTU5 and application thereof
CN103937819B (en) A kind of lilium regale wilson glutathione S-transferase gene LrGSTL1 and application thereof
CN104878027B (en) Yangbi bulla walnut ribonuclease gene JsRNase and application
CN101186916A (en) Gene sequence of coding perinereis albuhitensis grube cysteine protease inhibitor and its amino acid sequence and application
CN111411124B (en) Application of peanut hairy root strain in improving low-nitrogen and high-salt resistance of peanuts
Tzean et al. Cloning and characterization of cuticle-degrading serine protease from nematode-trapping fungus Arthrobotrys musiformis
Aggarwal et al. Cloning and expression of a small heat and salt tolerant protein (Hsp22) from Chaetomium globosum
CN103484467B (en) Diamondback moth cecropin 3, preparation method and application thereof
CN104152465A (en) Lilium regale cytochrome b5 gene LrCyt-b5 and application thereof
Harris et al. In vitro and in planta cyclization of target peptides using an asparaginyl endopeptidase from Oldenlandia affinis
CN106047892B (en) The purification process of Rhizoma Chuanxiong alpha-amylase/subtilisin inhibitor gene and expression product

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130213

Termination date: 20151208

EXPY Termination of patent right or utility model